Target intelligence / Profile preview

Enzymes of methylation metabolism

Molecular classification
Enzyme
01

Overview

Enzymes of methylation metabolism, primarily methyltransferases, catalyze the transfer of methyl groups from S-adenosylmethionine (SAM) to diverse substrates including DNA, histones, proteins, RNA, and small molecules, enabling critical epigenetic modifications and post-translational regulation. These enzymes are classified into structural types such as class I (Rossmann fold SAM-binding), class II (SET domain for histone methylation), class III (membrane-associated), and radical SAM variants, with functions spanning gene expression control via DNA and histone methylation, neurotransmitter metabolism (e.g., via COMT, PNMT, HNMT), and detoxification processes. Dysregulation contributes to diseases like cancer through aberrant epigenetics, cardiovascular issues via homocysteine buildup, and neurological/mood disorders from impaired neurotransmitter synthesis. The one-carbon metabolism cycle, involving methionine synthase and folate pathways, recycles homocysteine to sustain SAM production, highlighting nutritional dependencies on methionine and folate. While individual methyltransferases (e.g., DNMT1/3 for DNA) serve as therapeutic targets, the broad category lacks specific drugs but poses challenges like off-target epigenetic effects and toxicity from metabolic intermediates.

Other names
MethyltransferasesMethylation enzymesProtein methyltransferasesDNA methyltransferasesHistone methyltransferasesSAM-dependent methyltransferases
02

Biological functions

Gene expression regulationEpigenetic modificationDNA repairProtein function regulationNeurotransmitter synthesisDetoxificationSignal transduction
03

Disease associations

CancerCardiovascular diseaseNeurological disordersMood disordersAutoimmune disordersImmune dysfunction
04

Safety considerations

Homocysteine accumulation leading to toxicityOxidative stress from methylation imbalancePotential for epigenetic dysregulation

Beyond the preview

Go deeper on Enzymes of methylation metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzymes of methylation metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call